This content addresses the misinformation surrounding COVID vaccine clinical trials for young children, particularly regarding Novavax offering incentives for trial participation. It clarifies that participants are reimbursed for time and travel expenses, emphasizing the importance of this support. The article also advocates for utilizing safe and effective COVID vaccines for children in control groups.
